The Impact of Co-morbidity on Outcomes in Men with Advanced Prostate Cancer Treated with Chemotherapy (Docetaxel)

Side effects, or what are known as co-morbidities, often discourage men who have metastatic prostate cancer from continuing with chemotherapy (docetaxel). The question often asked is there a relationship between having side effects and the ultimate efficacy of the chemotherapy? In other words does having side effects have an effect on overall survival? To answer [...]

ZYTIGA – Potential Dosing Error – IMPORTANT

Error in ZYTIGA® Beginning Your Treatment Brochure It has come to Malecare's attention that the dosing schedule for ZYTIGA® (abiraterone acetate) is incorrectly described in the ZYTIGA® Beginning Your Treatment brochure. Please destroy the ZYTIGA® Beginning Your Treatment brochure and the ZYTIGA® Resource Kit. It contains inaccurate dosing information. Please ask your doctor, today, to ensure that you understand the appropriate dosing for ZYTIGA®. The recommended [...]

By |2017-10-19T10:46:38-04:00February 12th, 2016|Advanced Prostate Cancer, Uncategorized|4 Comments

Global Prostate Cancer Alliance

PROSTATE CANCER NETWORK Join here: https://healthunlocked.com/prostate-cancer-network A friendly, informal atmosphere where we can pick each other’s brains. Your 24 hour online support group. Talking about prostate cancer can be a powerful tool in learning to cope with it. Our community is run by the Prostate Cancer Network of the Global Prostate Cancer Alliance https://healthunlocked.com/prostate-cancer-network

By |2020-02-04T11:54:31-05:00February 9th, 2016|Newly Diagnosed|0 Comments

The Power Of A Cancer Diagnosis And How We Fail To Respond Positively

For cancer, January 2016 has been an unusual month.   This January, cancer has managed to take the lives of three world renowned entertainers; David Bowie, Alan Rickman and Terry Wogan. Examining their deaths, we see that they all were marked with great outpourings of grief from their loved ones, colleagues and their fans. But they [...]

PET/CT Scans More Sensitive Than CT and Bone Scans For Detecting Metastatic Prostate Cancer

According to an article in the Journal of Nuclear Medicine, researchers compared a PET/CT scan using the radiotracer F-18 DCFBC to conventional imaging modalities — an expanded Tc-99m-methylene diphosphonate (MDP) bone scan and contrast-enhanced CT of the chest, abdomen and pelvis — to detect prostate-specific membrane antigen (PSMA), which is associated with prostate cancer metastases. [...]

Go to Top